Clinical trial Recruiting at 1 site Observational

Monitoring transfusions during anesthesia in emergency situations

Official title: Biological Transfusion Efficiency Registry Transfusion Surveillance in Anaesthesia

Run by Erasme University Hospital · NCT06403163 · Data updated 2026-11-12

This study is looking at how blood transfusions are done during emergency surgeries to help improve future treatment guidelines for patients.

Quick facts

Study typeObservational
SexAll
Enrollment50000 (estimated)
SponsorErasme University Hospital
Academic / other
Locations1 site (Anderlecht)
StatusRecruiting
StartedSeptember 1, 2022
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedSeptember 2, 2025
Trial IDNCT06403163 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients who have received hemostatic products during anesthesia for active hemorrhage.

Probably not a fit

Patients who refuse to consent to data analysis and study participation will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect comprehensive data on transfusion practices during active hemorrhage in patients undergoing anesthesia. By gathering detailed information from patient files, the study seeks to facilitate modeling and analysis related to emergency transfusion protocols. The data collection will occur without altering the patients' management and will be limited to the acute management period. Patients will be informed about their inclusion in the registry during their anesthesia consultation.

Why it matters

Potential benefit: If successful, this study could enhance the safety and effectiveness of transfusion practices in emergency situations.

How similar studies have gone: While similar studies on transfusion practices exist, this specific approach to monitoring during anesthesia in emergency situations is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* all patients who have received an hemostasis product

Exclusion Criteria:

* patient who refused to consent to data analysis and study participation

Where it's running

  • Université libre de Bruxelles
    Anderlecht, Belgium
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.